ArticleCureus2024
Suspected Levonorgestrel-Releasing Intrauterine System (LNG-IUS)-Induced Secondary Adrenal Insufficiency: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Central adrenal insufficiency (CAI) is a rare endocrine disorder characterized by insufficient secretion of adrenocorticotropic hormone (ACTH) from the pituitary gland, resulting in decreased cortisol production. Here, we present the case of a 19-year-old female with suspected iatrogenic CAI possibly induced by a levonorgestrel-releasing intrauterine system (LNG-IUS). The patient presented with syncopal events, fatigue, and hypotension, prompting admission to the emergency department. Initial investigations revealed low morning cortisol levels and an inadequate cortisol response to ACTH stimulation, supporting the diagnosis of CAI. Treatment with glucocorticoid replacement therapy led to clinical improvement. Removal of the LNG-IUS led to the recovery of the hypothalamic-pituitary axis. Despite the absence of documented cases of LNG-IUS-induced CAI in literature, similarities with other progestin formulations suggest a potential mechanism involving interaction with glucocorticoid receptors. Further research is needed to elucidate the exact pathophysiology and evaluate the safety of LNG-IUS in relation to the hypothalamic-pituitary-adrenal (HPA) axis. This case underscores the importance of considering hormonal contraceptives as potential triggers of CAI in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.